![]() Life Technologies' MAX Efficiency DH5a Competent Cells now guard against infection by bacteriophage T5 |
Product development began when scientists at Life Technologies isolated a bacteriophage T5-resistant derivative of ...
Life Technologies' MAX Efficiency DH5a Competent Cells now guard against infection by bacteriophage T5 In the past, a researcher may have lost an Escherichia coli culture to a phage infection and just chalked it up to a failed transformation or inoculation. According to Heather Lustig, marketing manager for Life Technologies of Rockville, Md., bacteriophage contamination didn't really become a major concern until genome centers began sequencing large numbers of clones in parallel. Whereas good
![]() Life Technologies' MAX Efficiency DH5a Competent Cells now guard against infection by bacteriophage T5 |
Product development began when scientists at Life Technologies isolated a bacteriophage T5-resistant derivative of ...

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.


In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.

In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.


Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.


Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST

Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.

Collaboration will bring next generation orchestration and modular automation to scientists worldwide

The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.